Cargando…

The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview

Live attenuated Bacillus Calmette-Guérin (BCG) is the world’s most widely used vaccine which is mainly administered for its protection against tuberculosis (TB), particularly in young children. However, since its initial use over 100years ago, it has also proven to offer a level of protection agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mouhoub, Esma, Domenech, Pilar, Ndao, Momar, Reed, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566895/ https://www.ncbi.nlm.nih.gov/pubmed/34745066 http://dx.doi.org/10.3389/fmicb.2021.757858

Ejemplares similares

BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
por: Mustafa, Abu Salim
Publicado: (2020)

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
por: Perera, Dilhan J., et al.
Publicado: (2023)

The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles)
por: Chambers, Mark A., et al.
Publicado: (2017)

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
por: Kanipe, C., et al.
Publicado: (2022)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
por: Deng, Guoying, et al.
Publicado: (2020)

The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic
por: Yitbarek, Kiddus, et al.
Publicado: (2020)

BCG Vaccine: Tuberculosis—Cancer
por: Pimm, M. V.
Publicado: (1980)

BCG Vaccination and Tuberculosis in Japan
por: Rahman, Mahbubur, et al.
Publicado: (2007)

Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes
por: Faustman, Denise L., et al.
Publicado: (2022)

Promising Technologies in the Field of Helminth Vaccines
por: Perera, Dilhan J., et al.
Publicado: (2021)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

Diagnosis of Parasitic Diseases: Old and New Approaches
por: Ndao, Momar
Publicado: (2009)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
por: dos Santos, Carina C., et al.
Publicado: (2022)

The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection
por: Flores-Valdez, Mario A., et al.
Publicado: (2018)

The Diagnosis of Human Fascioliasis by Enzyme-Linked Immunosorbent Assay (ELISA) Using Recombinant Cathepsin L Protease
por: Gonzales Santana, Bibiana, et al.
Publicado: (2013)

Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice
por: Sonzogni-Desautels, Karine, et al.
Publicado: (2015)

Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
por: Velayutham, Banurekha, et al.
Publicado: (2023)

Recombinant HBHA Boosting Effect on BCG-Induced Immunity against Mycobacterium tuberculosis Infection
por: Guerrero, G. G., et al.
Publicado: (2011)

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Trypanosoma cruzi Infection and Host Lipid Metabolism
por: Miao, Qianqian, et al.
Publicado: (2014)

Mycobacterium tuberculosis and M. bovis BCG Moreau Fumarate Reductase Operons Produce Different Polypeptides That May Be Related to Non-canonical Functions
por: Schwarz, Marcos Gustavo Araujo, et al.
Publicado: (2021)

Motley Crew: Overview of the Currently Available Phage Diversity
por: Zrelovs, Nikita, et al.
Publicado: (2020)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
por: Muflihah, Heni, et al.
Publicado: (2021)

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
por: Wu, Juan, et al.
Publicado: (2022)

Infectious disease aerobiology: miasma incarnate
por: Roy, Chad J., et al.
Publicado: (2012)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
por: Koger-Pease, Cal, et al.
Publicado: (2023)

Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection
por: Xu, Zheng Zhong, et al.
Publicado: (2016)

Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis
por: Lemieux, Maxime W., et al.
Publicado: (2017)

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis
por: Ahn, Sang Kyun, et al.
Publicado: (2018)

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
por: Nascimento, Ivan P., et al.
Publicado: (2017)

Will Auranofin Become a Golden New Treatment Against COVID-19?
por: Sonzogni-Desautels, Karine, et al.
Publicado: (2021)

Vaccine-Induced Subcutaneous Granulomas in Goats Reflect Differences in Host–Mycobacterium Interactions between BCG- and Recombinant BCG-Derivative Vaccines
por: Liebler-Tenorio, Elisabeth M., et al.
Publicado: (2022)

Corrigendum: Motley Crew: Overview of the Currently Available Phage Diversity
por: Zrelovs, Nikita, et al.
Publicado: (2021)

Recombinant BCG to Enhance Its Immunomodulatory Activities
por: Kowalewicz-Kulbat, Magdalena, et al.
Publicado: (2022)

BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
por: Angelidou, Asimenia, et al.
Publicado: (2020)

Overview of the LHC Magnets other than the Main Dipoles
por: Siegel, N
Publicado: (2000)

New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
por: Gupta, Pramod Kumar
Publicado: (2020)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014)

Bcg: Miliary tuberculosis: case report
Publicado: (2021)

Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults
por: Szpakowski, Piotr, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8rms6k1he0jb90vge34bao5fjv